Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission

PHASE3CompletedINTERVENTIONAL

Enrollment

3,720

Participants

Timeline

Start Date

Not specified

Study Completion Date

November 30, 2004

Conditions

HIV Infections

Interventions

DRUG

Erythromycin

DRUG

Nevirapine

DRUG

Ampicillin sodium

DRUG

Metronidazole

Trial Locations (1)

Megan Valentine, Research Triangle Park

All Listed Sponsors

collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00021671 - Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission | Biotech Hunter | Biotech Hunter